🔗 Share this article

As the United States undertakes unprecedented revisions to its vaccine recommendations, one figure appears unexpectedly: Dr. Tracy Beth Høeg, a Danish American sports medicine doctor and epidemiologist who rose to prominence by expressing skepticism about Covid shots during the global health crisis and has concentrated on possible deaths after COVID-19 immunization in her recent position at the FDA.

Proposed Shifts to Pediatric Vaccine Schedule

Health officials had intended to unveil radical revisions to the pediatric vaccine schedule recently, bringing the US with Denmark’s vaccine program, it is understood – a substantial departure that would put the US out of step with many the world with no evidence for improved outcomes. This reveal has been pushed back until the coming year.

Instead of the director of the vaccine center, Høeg is scheduled to speak at the gathering. She was just designated acting director of the FDA’s CDER, the fifth individual to head the office this year.

A New Direction at the Regulatory Body

The acting appointment could signify a tighter collaboration between the drug and vaccine centers as Dr. Høeg and Dr. Prasad solidify control at the agency – and it signals a greater focus upon dismantling long-standing immunizations at the FDA.

Dr. Høeg has frequently advocated for halting specific pediatric vaccine recommendations in the US so as to align more similar to the Danish model, a society with universal health coverage and a number of inhabitants about the population of the state of Wisconsin.

In her initial comments, she has continued to focus on vaccination policy – usually the responsibility of Prasad, director of the FDA’s Center for Biologics Evaluation and Research (CBER) – as opposed to pharmaceutical oversight.

Questions Over Background

The appointee has no apparent background in pharmaceutical research, approval processes or management, which has been customary for past heads of the Center for Biologics Evaluation and Research. She has been employed at the FDA as a top consultant to the agency head and CBER since spring.

“It seems she lacks to have the requisite experience” for leading the drug-regulation department, said a neurologist and psychiatrist. “She’s never run a scientific study. She is not versed in running a major agency. She has no expertise in drug approvals.”

Past heads of CBER would “grasp laws and regulations and the research of pharmaceutical innovation”, noted Dr. Janet Woodcock. “Frankly, she has not acquired the sort of resume that previous people who ran the center have had.”

This division has an vast portfolio at the FDA, the former commissioner emphasized.

“The public just zeroes in on the innovative therapies, but the generic program authorizes a multitude of off-brand pharmaceuticals. There’s a biosimilars program, OTC medication office and more, and all of those must be looked after,” Woodcock explained. “The responsibility you neglect, that is the part that I always told people is going to come back to haunt you.”

Additionally, a significant administrative aspect to the position, which oversees more than 5,000 personnel. “It’s a enormous leadership role, if you do it right,” the former official concluded.

Official Statement and Controversial Policies

In response to questions about Høeg’s credentials and whether this assignment indicates more teamwork among FDA leaders on vaccines, a representative stated that the “concerns stem from inaccurate premises”.

“Her experience aligns with the duties of her job,” the official explained, citing the time Dr. Høeg spent counseling the agency head on “drug safety and regulatory science, including predictive safety algorithms and shot safety tracking”.

In her interim role, Høeg inherits the agency head's controversial expedited review system, a disputed one-day therapy clearance system that apparently troubled her former heads. “How are these drugs being chosen for this voucher program? Who takes the calls?” Howard asked. “There’s a lot of secrecy going on at the regulatory body right now.”

Overall, he remarked, “the agency looks to be trending towards less stringent oversight of most medications, aside from immunizations.”

Documented History on Immunizations

Regarding immunizations, Dr. Høeg has a clearer, if troubling, history, Howard said. She authored a analysis using unverified public submissions to estimate the incidence of heart inflammation following Covid vaccination. She consulted for the state of Florida chief medical officer Dr. Joseph Ladapo, who reportedly have changed statistics to suggest Covid vaccines are more dangerous than they are.

Included in her “desired changes” for the current administration featured altering guidelines for new vaccines and ending “non-essential” vaccines, she remarked after the election on a podcast. At the agency, Høeg has according to sources floated the idea of excluding adolescent males from receiving COVID-19 vaccinations.

“She is an complete true believer who commences with her conclusions and works backwards to retrofit the science in a extremely misleading, fraudulent manner,” Dr. Howard stated.

Consolidating Power and a “Revenge Tour”

Høeg became part of fellow skeptics, {like|